ENTITY

Access Bio Inc (950130 KS)

Analysis

Health Care • South Korea

Access Bio Inc. develops, manufactures, and markets in-vitro diagnostic (IVD) tests. The Company develops rapid diagnostic test (RDT) for Malaria and Pregnancy.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00